GetTopicDetailResponse(id=271185668ef, topicName=腹膜間皮瘤, introduction=腹膜間皮瘤, content=null, image=null, comments=2, allHits=1118, url=https://h5.medsci.cn/topic?id=85668, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=102821, tagList=[TagDto(tagId=102821, tagName=腹膜間皮瘤)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2010659, encodeId=32d920106596c, content=<a href='/topic/show?id=271185668ef' target=_blank style='color:#2F92EE;'>#腹膜間皮瘤#</a>, objectTitle=Thorax：惡性胸膜和腹膜間皮瘤的發(fā)病率、治療和生存率, objectType=article, longId=295589, objectId=89fd2955899b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89fd2955899b, replyNumber=0, likeNumber=99, createdTime=2022-04-04, rootId=0, userName=nymo, userId=560d188, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89fd2955899b, moduleTitle=Thorax：惡性胸膜和腹膜間皮瘤的發(fā)病率、治療和生存率, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=89fd2955899b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2010658, encodeId=283d20106586a, content=<a href='/topic/show?id=271185668ef' target=_blank style='color:#2F92EE;'>#腹膜間皮瘤#</a>, objectTitle=Cancer Discov：阿替利珠單抗（atezolizumab）聯(lián)合貝伐珠單抗（bevacizumab）治療惡性腹膜間皮瘤（MPeM）的療效, objectType=article, longId=214989, objectId=b1e72149892f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1e72149892f, replyNumber=0, likeNumber=107, createdTime=2021-11-05, rootId=0, userName=nymo, userId=560d188, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1e72149892f, moduleTitle=Cancer Discov：阿替利珠單抗（atezolizumab）聯(lián)合貝伐珠單抗（bevacizumab）治療惡性腹膜間皮瘤（MPeM）的療效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b1e72149892f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
